Insider · CIK 0001875057
Peter Olagunju
Files at TCRR (TCR2 THERAPEUTICS INC.). First filing Dec 5, 2022, latest Dec 13, 2022.
In brief
Peter Olagunju files SEC Form 4 as COO at TCRR (TCR2 THERAPEUTICS INC.). Since Dec 5, 2022, Peter Olagunju has reported 0 open-market buys worth $0 and 4 open-market sells worth $14k, the latest filed on Dec 13, 2022.
A track record needs three past buys with six months of prices behind them; Peter Olagunju has 0, so none is measured yet.
The newest scored trade: sold $5,299 of TCRR on Dec 9, 2022, filed Dec 13, 2022, scored 15 (weak), under a 10b5-1 plan.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | TCR2 THERAPEUTICS INC. | $5,299 4,830 shares | -17% | - | |
| 10Weak | TCR2 THERAPEUTICS INC. | $3,533 2,788 shares | -9% | - | |
| 10Weak | TCR2 THERAPEUTICS INC. | $3,531 2,618 shares | -8% | - | |
| 0Weak | TCR2 THERAPEUTICS INC. | $1,766 1,273 shares | -4% | - |
Transactions
Every row this insider has filed, 21 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Common Stock | -24,092 | - | - | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -98,124 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -47,100 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Restricted Stock Unitderivative | -16,354 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Jun 1, 2023 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Restricted Stock Unitderivative | -62,047 | $0.00 | $0 | 0 | Jun 1, 2023 |
| Dec 15, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Stock Option (Right to Buy)derivative | +98,124 | $0.00 | $0 | 98,124 | Dec 19, 2022 |
| Dec 15, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Restricted Stock Unit (Right to Buy)derivative | +16,354 | $0.00 | $0 | 16,354 | Dec 19, 2022 |
| Dec 9, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,561 | $1.13 | $1,765 | 27,361 | Dec 13, 2022 |
| Dec 12, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,610 | $1.10 | $1,766 | 25,751 | Dec 13, 2022 |
| Dec 13, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,659 | $1.07 | $1,767 | 24,092 | Dec 13, 2022 |
| Dec 7, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,378 | $1.28 | $1,767 | 30,332 | Dec 9, 2022 |
| Dec 8, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,410 | $1.25 | $1,767 | 28,922 | Dec 9, 2022 |
| Dec 5, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,291 | $1.37 | $1,766 | 33,037 | Dec 7, 2022 |
| Dec 6, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,327 | $1.33 | $1,765 | 31,710 | Dec 7, 2022 |
| Dec 1, 2022 | TCRR TCR2 THERAPEUTICS INC. | MOption exercise Common Stock | +33,409 | - | - | 35,601 | Dec 5, 2022 |
| Dec 2, 2022 | TCRR TCR2 THERAPEUTICS INC. | SOpen-market sale Common Stock10b5-1 | -1,273 | $1.39 | $1,766 | 34,328 | Dec 5, 2022 |
| Dec 1, 2022 | TCRR TCR2 THERAPEUTICS INC. | MOption exercise Restricted Stock Unitderivative | +33,409 | $0.00 | $0 | 62,047 | Dec 5, 2022 |
| Nov 17, 2022 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (right to buy)derivative | -31,520 | $0.00 | $0 | 0 | Nov 18, 2022 |
| Nov 17, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Restricted Stock Unit (right to buy)derivative | +10,507 | $0.00 | $0 | 10,507 | Nov 18, 2022 |
| Nov 17, 2022 | TCRR TCR2 THERAPEUTICS INC. | DDisposition to issuer Stock Option (right to buy)derivative | -254,847 | $0.00 | $0 | 0 | Nov 18, 2022 |
| Nov 17, 2022 | TCRR TCR2 THERAPEUTICS INC. | AGrant or award Restricted Stock Unit (right to buy)derivative | +84,949 | $0.00 | $0 | 84,949 | Nov 18, 2022 |
Questions about Peter Olagunju
Answered from the filings on this page, as of the latest one.
Is Peter Olagunju buying or selling?
Not in the last 12 months. Peter Olagunju's latest open-market trade on SEC Form 4 was sold $5,299 of TCRR on Dec 9, 2022.
How did Peter Olagunju's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Olagunju has 0.
Where does Peter Olagunju file Form 4?
Peter Olagunju has filed Form 4 at TCRR (TCR2 THERAPEUTICS INC.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.